Postoperative radiotherapy versus systemic therapy alone for locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy
Neoadjuvant chemoimmunotherapy (nICT) followed by radical esophagectomy is increasingly used for locally advanced esophageal squamous cell carcinoma (LA-ESCC), but the incremental value of postoperative radiotherapy (PORT) in patients who also receive postoperative systemic therapy remains uncertain. This study eva...